Deutsche Bank Maintains Buy on Tenet Healthcare, Raises Price Target to $155
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Pito Chickering maintains a Buy rating on Tenet Healthcare (NYSE:THC) and raises the price target from $150 to $155.
June 28, 2024 | 5:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Deutsche Bank has reaffirmed its Buy rating on Tenet Healthcare and increased the price target from $150 to $155, indicating confidence in the company's future performance.
The reaffirmation of a Buy rating and an increased price target from a reputable analyst at Deutsche Bank suggests positive sentiment and expected growth for Tenet Healthcare. This is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100